Abstract

Developing B cells undergo defined maturation steps in the bone marrow and in the spleen. The timing and the factors that control these differentiation steps are not fully understood. By targeting the B cell-restricted mb-1 locus to generate an mb-1 allele that expresses a tamoxifen inducible Cre and another allele in which mb-1 expression can be controlled by Cre, we have established a mouse model with an inducible B cell compartment. With these mice, we studied in detail the kinetics of B cell development and the consequence of BCR activation at a defined B cell maturation stage. Contrary to expectations, transitional 1-B cells exposed to anti-IgM reagents in vivo did not die but instead developed into transitional 2 (T2)-B cells with upregulated Bcl-2 expression. We show, however, that these T2-B cells had an increased dependency on the B cell survival factor B cell activating factor when compared to non-stimulated B cells. Overall, our findings indicate that the inducible mb-1 mouse strain represents a useful model, which allows studying the signals that control the selection of B cells in greater detail.

Highlights

  • B cell lymphopoiesis is a highly regulated process that begins with B cell progenitors and progresses through distinct stages [1,2,3]

  • In these mice the expression of the mb-1 gene, which is essential for B cell development, can be regulated by our MerCreMer/loxP technique

  • We show that the tamoxifen-induced MerCreMer recombinase is tightly regulated in vivo and can be used to activate genes in the mouse

Read more

Summary

Introduction

B cell lymphopoiesis is a highly regulated process that begins with B cell progenitors (pro-B cells) and progresses through distinct stages [1,2,3]. The loss of Igα or Igβ expression in knockout mice [4,5,6], or in rare cases of human Igα or Igβ deficiency [7,8,9], results in a complete block of B cell development at the pro-B cell stage. This is because the developmental progression of pro-B cells requires the expression of the precursor B cell antigen receptor (pre-BCR) [10, 11]. The immature B cells leave the bone marrow (BM) to continue their differentiation in the spleen [15,16,17,18,19]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call